Table 2.

Indications currently approved for reimbursement for FDG PET by the U.S. Center for Medicare and Medicaid Services

Cancer Type	Indication
Breast	Staging of distant metastasis, restaging monitoring
Cervical	Staging as adjunct to conventional imaging
Colorectal	Diagnosis, staging and restaging
Esophagus	Diagnosis, staging and restaging
Head and Neck	Diagnosis, staging and restaging
Lymphoma	Diagnosis, staging and restaging
Melanoma	Diagnosis, staging and restaging
Non-small cell lung cancer	Diagnosis, staging and restaging
Solitary Pulmonary Nodule	Characterization